Showing results (1-10 of 12) with videos related to
Sort By:
Pageof 2
Cancer Chemotherapy and Pharmacology|August 6, 2017
Continuous low plasma concentrations of everolimus provides equivalent efficacy to oral daily dosing in mouse xenograft models of human cancerLaurent Laborde, Fatos Oz, Mitko Ristov, et al.La Revue Du Praticien|March 4, 2009
[Developing patient information sheets in general practice. Proposal for a methodology]Mélanie Sustersic, Aurélia Meneau, Roger Drémont, et al.Acta Paediatrica (Oslo, Norway : 1992)|June 20, 2007
Breastfeeding outcomes for mothers with and without home access to e-technologiesLaurent Laborde, Nathalie Gelbert-Baudino, Julie Fulcheri, et al.BMC Infectious Diseases|March 16, 2011
Requesting physicians' experiences regarding infectious disease consultationsPatricia Pavese, Elodie Sellier, Laurent Laborde, et al.Maternal & Child Nutrition|June 22, 2011
CD-ROM-based program for breastfeeding mothersJosé Labarère, Nathalie Gelbert-Baudino, Laurent Laborde, et al.Journal of Human Lactation : Official Journal of International Lactation Consultant Association|February 21, 2012
Determinants of 6-month maternal satisfaction with breastfeeding experience in a multicenter prospective cohort studyJosé Labarère, Nathalie Gelbert-Baudino, Laurent Laborde, et al.Anti-Cancer Drugs|May 8, 2018
Continuous low-dose infusion of patupilone increases the therapeutic index in mouse and rat tumour modelsMike Becquet, Laurent Laborde, Celine Texier, et al.BMC Plant Biology|June 23, 2010
Identification of novel genes potentially involved in somatic embryogenesis in chicory (Cichorium intybus L.)Anca Lucau-Danila, Laurent Laborde, Sylvain Legrand, et al.Bioconjugate Chemistry|January 24, 2024
Design, Synthesis, and In Vitro and In Vivo Evaluation of Cereblon Binding Bruton's Tyrosine Kinase (BTK) Degrader CD79b Targeted Antibody-Drug ConjugatesAlan Zhang, Katherine Seiss, Laurent Laborde, et al.Proceedings of the National Academy of Sciences of the United States of America|April 22, 2026
Targeting CRTC2 reverses <i>STK11</i> mutant NSCLC tumor resistance to immunotherapyDimitri Robay, Ole Ackermann, Laurent Laborde, et al.Pageof 2